Liver Embolization Approaches for Tumor Management

Launched by IRCCS SAN RAFFAELE · Feb 3, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring different techniques to treat liver tumors in patients with conditions like liver cancer and metastatic cancers. The main goal is to see how well these methods help patients live longer without their cancer getting worse and to understand how these treatments affect the liver's ability to recover and grow. This study will not involve any extra procedures; participants will continue with their usual treatment plans as determined by their doctors.

To join the study, participants must be at least 18 years old and have liver tumors that can’t be treated with surgery or other common methods. Some patients who may benefit from surgery in the future are also eligible. However, pregnant women and those with certain serious health issues won’t be able to participate. If you decide to take part, you will provide consent and follow your regular treatment while the researchers observe the outcomes of your care. This trial is currently recruiting participants, and it aims to contribute important information about treating liver tumors effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥ 18 yoa
• • patients with patients with primary or secondary liver disease not amenable for surgery or ablation
• • patients with primary or secondary liver tumors candidates for major surgery prior to induction of hypertrophy
• • able and willing to sign informed consent
• Exclusion Criteria:
• • pregnant women
• • patients with uncorrectable coagulopathy
• • diffuse extrahepatic disease
• • for lobar TACE and TARE - presence of bilodigestive shunt
• • for TARE - \>20% hepatopulmonary shunt